Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
8
pubmed:dateCreated
1999-7-29
pubmed:abstractText
1. The receptor subtype and mechanisms underlying relaxation to adenosine were examined in human isolated small coronary arteries contracted with the thromboxane A2 mimetic, 1,5,5-hydroxy-11alpha, 9alpha-(epoxymethano)prosta-5Z, 13E-dienoic acid (U46619) to approximately 50% of their maximum contraction to K+ (125 mM) depolarization (Fmax). Relaxations were normalized as percentages of the 50% Fmax contraction. 2. Adenosine caused concentration-dependent relaxations (pEC50, 5.95+/-0.20; maximum relaxation (Rmax), 96.7+/-1.4%) that were unaffected by either combined treatment with the nitric oxide inhibitors, NG-nitro-L-arginine (L-NOARG; 100 microM) and oxyhaemoglobin (HbO; 20 microM) or the ATP-dependent K+ channel (KATP) inhibitor, glibenclamide (10 microM). The pEC50 but not Rmax to adenosine was significantly reduced by high extracellular K+ (30 mM). Relaxations to the adenylate cyclase activator, forskolin, however, were unaffected by high K+ (30 mM). 3. Adenosine and a range of adenosine analogues, adenosine, 2-chloroadenosine (2-CADO), 5'-N-ethyl-carboxamidoadenosine (NECA), R(-)-N6-(2-phenylisopropyl)-adenosine (R-PIA), S(+)-N6-(2-phenylisopropyl)-adenosine (S-PIA), N6-cyclopentyladenosine (CPA), 1-deoxy-1-[6-[[(3-iodophenyl)methyl]amino]-9H-purin-9-yl]-N-methyl-beta- D-ribofuranuronamide (IB-MECA), 2-p-(2-carboxyethyl)phenethylamino-5'-N-ethylcarboxamido adenosine hydrochloride (CGS 21680), relaxed arteries with a rank order of potency of NECA= 2-CADO >adenosine= IB-MECA = R-PIA= CPA > S-PIA)> CGS 21680. 4. Sensitivity but not Rmax to adenosine was significantly reduced approximately 80 and 20 fold by the non-selective adenosine receptor antagonist, 8-(p-sulphophenyl)theophylline (8-SPT) and the A2 receptor antagonist, 3,7-dimethyl-1-propargylxanthine (DMPX). By contrast, the A1-selective antagonist, 1,3-dipropyl-8-cyclopentylxanthine (DPCPX) had no effect on pEC50 or Rmax to adenosine. 5. These results suggest that A2B receptors mediate relaxation to adenosine in human small coronary arteries which is independent of NO but dependent in part on a K+-sensitive mechanism.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/10372822-1397010, http://linkedlifedata.com/resource/pubmed/commentcorrection/10372822-2032388, http://linkedlifedata.com/resource/pubmed/commentcorrection/10372822-2043923, http://linkedlifedata.com/resource/pubmed/commentcorrection/10372822-3215272, http://linkedlifedata.com/resource/pubmed/commentcorrection/10372822-6254686, http://linkedlifedata.com/resource/pubmed/commentcorrection/10372822-7582485, http://linkedlifedata.com/resource/pubmed/commentcorrection/10372822-7582508, http://linkedlifedata.com/resource/pubmed/commentcorrection/10372822-7582525, http://linkedlifedata.com/resource/pubmed/commentcorrection/10372822-7651967, http://linkedlifedata.com/resource/pubmed/commentcorrection/10372822-8135838, http://linkedlifedata.com/resource/pubmed/commentcorrection/10372822-8296392, http://linkedlifedata.com/resource/pubmed/commentcorrection/10372822-8358543, http://linkedlifedata.com/resource/pubmed/commentcorrection/10372822-8358566, http://linkedlifedata.com/resource/pubmed/commentcorrection/10372822-8377834, http://linkedlifedata.com/resource/pubmed/commentcorrection/10372822-8458033, http://linkedlifedata.com/resource/pubmed/commentcorrection/10372822-8503914, http://linkedlifedata.com/resource/pubmed/commentcorrection/10372822-8558444, http://linkedlifedata.com/resource/pubmed/commentcorrection/10372822-8680745, http://linkedlifedata.com/resource/pubmed/commentcorrection/10372822-8943953, http://linkedlifedata.com/resource/pubmed/commentcorrection/10372822-8979771, http://linkedlifedata.com/resource/pubmed/commentcorrection/10372822-9138678, http://linkedlifedata.com/resource/pubmed/commentcorrection/10372822-9175581, http://linkedlifedata.com/resource/pubmed/commentcorrection/10372822-9443164, http://linkedlifedata.com/resource/pubmed/commentcorrection/10372822-9495868, http://linkedlifedata.com/resource/pubmed/commentcorrection/10372822-9581720, http://linkedlifedata.com/resource/pubmed/commentcorrection/10372822-9715864
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Apr
pubmed:issn
0007-1188
pubmed:author
pubmed:issnType
Print
pubmed:volume
126
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1796-800
pubmed:dateRevised
2010-11-18
pubmed:meshHeading
pubmed-meshheading:10372822-Adenosine, pubmed-meshheading:10372822-Aged, pubmed-meshheading:10372822-Coronary Vessels, pubmed-meshheading:10372822-Endothelium, Vascular, pubmed-meshheading:10372822-Enzyme Inhibitors, pubmed-meshheading:10372822-Female, pubmed-meshheading:10372822-Humans, pubmed-meshheading:10372822-Male, pubmed-meshheading:10372822-Middle Aged, pubmed-meshheading:10372822-Muscle Relaxation, pubmed-meshheading:10372822-Nitric Oxide, pubmed-meshheading:10372822-Nitroarginine, pubmed-meshheading:10372822-Oxyhemoglobins, pubmed-meshheading:10372822-Potassium, pubmed-meshheading:10372822-Potassium Channels, pubmed-meshheading:10372822-Purinergic P1 Receptor Antagonists, pubmed-meshheading:10372822-Receptor, Adenosine A2B, pubmed-meshheading:10372822-Receptors, Purinergic P1, pubmed-meshheading:10372822-Vascular Resistance, pubmed-meshheading:10372822-Vasodilator Agents
pubmed:year
1999
pubmed:articleTitle
Adenosine mediates relaxation of human small resistance-like coronary arteries via A2B receptors.
pubmed:affiliation
Department of Pharmacology, The University of Melbourne, Parkville, Victoria, Australia.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't